Sign in
4

Changes in Ownership

OptimizeRx Corp Filed Acc 0001628280-24-052490

Chief Commercial Officer acquired 41,408 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Silvestro Stephen L Chief Commercial Officer 2024-12-23 Grant or award +41,408 122,256 D
Derivatives
Silvestro Stephen L Chief Commercial Officer 2024-12-23 Grant or award · Stock Option +77,742 77,742 D
Loading xslF345X05/wk-form4_1735330727.xml…